Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Platelets ; 27(4): 378-80, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26556301

ABSTRACT

High expression of the collagen receptor, α2ß1 integrin, on platelets of ITGA2 807T-allele carriers has been identified as a risk factor for thromboembolic conditions, and α2ß1 inhibitors are considered to be potential therapeutic agents. In 59 genotyped individuals, we measured α2 expression levels on platelets and analyzed platelet adhesion to collagen under flow conditions. A sulfonamide-type small-molecule inhibitor of α2ß1 integrin decreased average platelet adhesion in individuals with the C/T807T genotype but not in those harboring C807C. Thus, genotype can be used to select a human subpopulation that has the highest probability of showing a positive response to α2ß1 inhibitors.


Subject(s)
Blood Platelets/drug effects , Blood Platelets/metabolism , Integrin alpha2beta1/antagonists & inhibitors , Integrin alpha2beta1/genetics , Polymorphism, Single Nucleotide , Adult , Alleles , Amino Acid Chloromethyl Ketones/pharmacology , Animals , Collagen/metabolism , Female , Genotype , Humans , Integrin alpha2beta1/metabolism , Male , Mice , Middle Aged , Pharmacogenomic Variants , Protein Binding , Young Adult
2.
Pharmacol Res Perspect ; 3(3): e00146, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26171226

ABSTRACT

Small molecule inhibitors of α2ß1 integrin, a major cellular collagen receptor, have been reported to inhibit platelet function, kidney injury, and angiogenesis. Since α2ß1 integrin is abundantly expressed on various inflammation-associated cells, we tested whether recently developed α2ß1 blocking sulfonamides have anti-inflammatory properties. Integrin α2ß1 inhibitors were shown to reduce the signs of inflammation in arachidonic acid-induced ear edema, PAF stimulated air pouch, ovalbumin-induced skin hypersensitivity, adjuvant arthritis, and collagen-induced arthritis. Thus, these sulfonamides are potential drugs for acute and allergic inflammation, hypersensitivity, and arthritis. One sulfonamide with potent anti-inflammatory activity has previously been reported to be selective for activated integrins, but not to inhibit platelet function. Thus, the experiments also revealed fundamental differences in the action of nonactivated and activated α2ß1 integrins in inflammation when compared to thrombosis.

3.
J Biol Chem ; 287(53): 44694-702, 2012 Dec 28.
Article in English | MEDLINE | ID: mdl-23132859

ABSTRACT

The interaction between α2ß1 integrin (GPIa/IIa, VLA-2) and vascular collagen is one of the initiating events in thrombus formation. Here, we describe two structurally similar sulfonamide derivatives, BTT-3033 and BTT-3034, and show that, under static conditions, they have an almost identical effect on α2-expressing CHO cell adhesion to collagen I, but only BTT-3033 blocks platelet attachment under flow (90 dynes/cm(2)). Differential scanning fluorimetry showed that both molecules bind to the α2I domain of the recombinant α2 subunit. To further study integrin binding mechanism(s) of the two sulfonamides, we created an α2 Y285F mutant containing a substitution near the metal ion-dependent adhesion site motif in the α2I domain. The action of BTT-3033, unlike that of BTT-3034, was dependent on Tyr-285. In static conditions BTT-3034, but not BTT-3033, inhibited collagen binding by an α2 variant carrying a conformationally activating E318W mutation. Conversely, in under flow conditions (90 dynes/cm(2)) BTT-3033, but not BTT-3034, inhibited collagen binding by an α2 variant expressing E336A loss-of-function mutation. Thus, the binding sites for BTT-3033 and BTT-3034 are differentially available in distinct integrin conformations. Therefore, these sulfonamides can be used to study the biological role of different functional stages of α2ß1. Furthermore, only the inhibitor that recognized the non-activated conformation of α2ß1 integrin under shear stress conditions effectively blocked platelet adhesion, suggesting that the initial interaction between integrin and collagen takes place prior to receptor activation.


Subject(s)
Collagen Type I/metabolism , Integrin alpha2beta1/antagonists & inhibitors , Integrin alpha2beta1/metabolism , Platelet Membrane Glycoproteins/metabolism , Sulfonamides/metabolism , Animals , Blood Platelets/chemistry , Blood Platelets/cytology , Blood Platelets/metabolism , Cell Adhesion/drug effects , Cell Line , Humans , Integrin alpha2beta1/genetics , Mice , Mice, Inbred C57BL , Molecular Structure , Platelet Membrane Glycoproteins/genetics , Protein Binding/drug effects , Stress, Mechanical , Sulfonamides/pharmacology
4.
Mol Cancer Res ; 10(5): 597-604, 2012 May.
Article in English | MEDLINE | ID: mdl-22522458

ABSTRACT

TGF-ß regulates several steps in cancer metastasis, including the establishment of bone metastatic lesions. TGF-ß is released from bone during osteoclastic bone resorption and it stimulates breast cancer cells to produce osteolytic factors such as interleukin 11 (IL-11). We conducted a cell-based siRNA screen and identified heparan sulfate 6-O-sulfotransferase 2 (HS6ST2) as a critical gene for TGF-ß-induced IL-11 production in highly bone metastatic MDA-MB-231(SA) breast cancer cells. HS6ST2 attaches sulfate groups to glucosamine residues in heparan sulfate glycosaminoglycans. We subsequently showed how heparin and a high-molecular-weight Escherichia coli K5-derived heparin-like polysaccharide (K5-NSOS) inhibited TGF-ß-induced IL-11 production in MDA-MB-231(SA) cells. In addition, K5-NSOS inhibited bone resorption activity of human osteoclasts in vitro. We evaluated the therapeutic potential of K5-NSOS and fragmin in a mouse model of breast cancer bone metastasis. MDA-MB-231(SA) cells were inoculated into the left cardiac ventricle of athymic nude mice which were treated with fragmin, K5-NSOS, or vehicle once a day for four weeks. Both heparin-like glycosaminoglycans inhibited weight reduction, decreased osteolytic lesion area, and reduced tumor burden in bone. In conclusion, our data imply novel mechanisms involved in TGF-ß induction and support the critical role of heparan sulfate glycosaminoglycans in cancer metastasis as well as indicate that K5-NSOS is a potential antimetastatic and antiresorptive agent for cancer therapy. This study illustrates the potential to translate in vitro siRNA screening results toward in vivo therapeutic concepts.


Subject(s)
Bacterial Capsules , Heparin , Osteoclasts/drug effects , Sulfotransferases , Animals , Bacterial Capsules/chemistry , Bone Neoplasms/metabolism , Bone Neoplasms/secondary , Bone Resorption/genetics , Bone Resorption/pathology , Breast Neoplasms/metabolism , Cell Line, Tumor , Female , Gene Expression Regulation, Neoplastic/drug effects , Heparin/chemistry , Heparin/pharmacology , Humans , Interleukin-11/antagonists & inhibitors , Interleukin-11/metabolism , Mice , Mice, Nude , RNA, Small Interfering , Sulfotransferases/antagonists & inhibitors , Sulfotransferases/genetics , Sulfotransferases/metabolism , Transforming Growth Factor beta/antagonists & inhibitors , Transforming Growth Factor beta/metabolism
5.
J Am Chem Soc ; 133(37): 14558-61, 2011 Sep 21.
Article in English | MEDLINE | ID: mdl-21863823

ABSTRACT

Collagen binding integrins are an important family of cell surface receptors that mediate bidirectionally signals between the interior of the cell and the extracellular matrix. The protein-protein interactions between cells and collagen are necessary for many physiological functions, but also promote diseases. For example, the interaction of α2ß1 integrin and collagen has been shown to have an important role in thrombus formation and cancer spread. The fact that the discovery of small molecules that can block such protein-protein interactions is highly challenging has significantly hindered the discovery of pharmaceutical agents to treat these diseases. Here, we present a rationally designed novel fluorescent molecule that can be synthesized in just a few minutes from commercially available starting materials. This molecule blocks the protein-protein interaction between α2ß1 integrin and collagen, and due to its fluorescent properties, it can be employed in wide variety of biological applications.


Subject(s)
Fluorescent Dyes/metabolism , Integrin alpha2beta1/metabolism , Binding Sites , Collagen/metabolism , Fluorescent Dyes/chemistry , Humans , Integrin alpha2beta1/chemistry , Models, Molecular , Protein Binding , Spectrometry, Fluorescence
6.
Semin Thromb Hemost ; 33(5): 547-56, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17629853

ABSTRACT

Heparin-like polysaccharides possess the capacity to inhibit cancer cell proliferation, angiogenesis, heparanase-mediated cancer cell invasion, and cancer cell adhesion to vascular endothelia via adhesion receptors, such as selectins. The clinical applicability of the antitumor effect of such polysaccharides, however, is compromised by their anticoagulant activity. We have compared the potential of chemically O-sulfated and N,O-sulfated bacterial polysaccharide (capsular polysaccharide from E. COLI K5 [K5PS]) species to inhibit metastasis of mouse B16-BL6 melanoma cells and human MDA-MB-231 breast cancer cells in two in vivo models. We demonstrate that in both settings, O-sulfated K5PS was a potent inhibitor of metastasis. Reducing the molecular weight of the polysaccharide, however, resulted in lower antimetastatic capacity. Furthermore, we show that O-sulfated K5PS efficiently inhibited the invasion of B16-BL6 cells through Matrigel and also inhibited the in vitro activity of heparanase. Moreover, treatment with O-sulfated K5PS lowered the ability of B16-BL6 cells to adhere to endothelial cells, intercellular adhesion molecule-1, and P-selectin, but not to E-selectin. Importantly, O-sulfated K5PSs were largely devoid of anticoagulant activity. These findings indicate that O-sulfated K5PS polysaccharide should be considered as a potential antimetastatic agent.


Subject(s)
Breast Neoplasms/enzymology , Melanoma/enzymology , Neoplasm Metastasis/prevention & control , Polysaccharides, Bacterial/pharmacology , Animals , Bacterial Capsules , Bone Neoplasms/prevention & control , Bone Neoplasms/secondary , Breast Neoplasms/pathology , Cell Adhesion/drug effects , Cell Line , E-Selectin/metabolism , Endothelial Cells/metabolism , Endothelial Cells/pathology , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Female , Heparin Lyase/antagonists & inhibitors , Heparin Lyase/metabolism , Humans , Intercellular Adhesion Molecule-1/metabolism , Lung Neoplasms/prevention & control , Lung Neoplasms/secondary , Melanoma/pathology , Mice , Neoplasm Metastasis/pathology , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/metabolism , P-Selectin/metabolism , Polysaccharides, Bacterial/therapeutic use
7.
J Med Chem ; 50(11): 2742-6, 2007 May 31.
Article in English | MEDLINE | ID: mdl-17447751

ABSTRACT

Integrin alpha2beta1 is a potential target molecule in drug development. We have established "design" criteria for molecules that bind to the "closed" conformation of alpha2I domain via Mg(2+) in MIDAS (metal ion dependent adhesion site) while simultaneously forming interactions with neighboring amino acid residues. Specific tetracyclic Streptomyces products belonging to the group of aromatic polyketides fulfill our criteria and inhibit alpha2beta1 integrin. All previously described inhibitors of alphaI domain integrins act in an allosteric manner.


Subject(s)
Integrins/antagonists & inhibitors , Integrins/metabolism , Magnesium/metabolism , Tetracyclines/chemistry , Animals , Binding Sites , CHO Cells , Cations, Divalent , Cell Adhesion , Cricetinae , Cricetulus , Drug Design , Humans , Integrins/chemistry , Models, Molecular , Protein Conformation , Protein Structure, Tertiary , Streptomyces/chemistry , Tetracyclines/isolation & purification , Tetracyclines/pharmacology
8.
Br J Pharmacol ; 144(2): 165-77, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15655522

ABSTRACT

1. Zebrafish has five distinct alpha(2)-adrenoceptors. Two of these, alpha(2Da) and alpha(2Db), represent a duplicated, fourth alpha(2)-adrenoceptor subtype, while the others are orthologue of the human alpha(2A)-, alpha(2B)- and alpha(2C)-adrenoceptors. Here, we have compared the pharmacological properties of these receptors to infer structural determinants of ligand interactions. 2. The zebrafish alpha(2)-adrenoceptors were expressed in Chinese hamster ovary cells and tested in competitive ligand binding assays and in a functional assay (agonist-stimulated [(35)S]GTPgammaS binding). The affinity results were used to cluster the receptors and, separately, the ligands using both principal component analysis and binary trees. 3. The overall ligand binding characteristics, the order of potency and efficacy of the tested agonists and the G-protein coupling of the zebrafish and human alpha(2)-adrenoceptors, separated by approximately 350 million years of evolution, were found to be highly conserved. The binding affinities of the 20 tested ligands towards the zebrafish alpha(2)-adrenoceptors are generally comparable to those of their human counterparts, with a few compounds showing up to 40-fold affinity differences. 4. The alpha(2A) orthologues and the zebrafish alpha(2D) duplicates clustered as close pairs, but the relationships between the orthologues of alpha(2B) and alpha(2C) were not clearly defined. Applied to the ligands, our clustering methods segregated the ligands based on their chemical structures and functional properties. As the ligand binding pockets formed by the transmembrane helices show only minor differences among the alpha(2)-adrenoceptors, we suggest that the second extracellular loop--where significant sequence variability is located --might contribute significantly to the observed affinity differences.


Subject(s)
Conserved Sequence , Receptors, Adrenergic, alpha-2/chemistry , Receptors, Adrenergic, alpha-2/classification , Zebrafish/metabolism , Animals , CHO Cells , Cricetinae , Humans , Protein Binding/physiology , Protein Structure, Secondary/physiology , Receptors, Adrenergic, alpha-2/metabolism
9.
Mol Biol Evol ; 21(1): 14-28, 2004 Jan.
Article in English | MEDLINE | ID: mdl-12949138

ABSTRACT

The alpha(2)-adrenergic receptors (alpha(2)-ARs) belong to the large family of rhodopsinlike G-protein-coupled receptors that share a common structure of seven transmembrane (TM) alpha-helices. The aims of this study were (1) to determine the number of alpha(2)-AR genes in a teleost fish, the zebrafish (Danio rerio), (2) to study the gene duplication events that generated the alpha(2)-AR subtypes, and (3) to study changes in receptor structure that have occurred since the divergence of the mammalian and fish lineages. Here, we report the cloning and chromosomal mapping of fish orthologs for all three mammalian alpha(2)-ARs. In addition, we identified a fourth alpha(2)-AR subtype with two duplicates in zebrafish. Chromosomal mapping showed that the zebrafish alpha(2)-AR genes are located within conserved chromosomal segments, consistent with the origin of the four alpha(2)-AR subtypes by two rounds of chromosome or block duplication before the divergence of the ray fin fish and tetrapod lineages. Thus, the fourth subtype has apparently been present in the common ancestor of vertebrates but has been deleted or is yet to be identified in mammals. The overall percentage identity between the fish and mammalian orthologs is 53% to 67%, and in the TM regions 80% to 87%. These values are clearly lower than what is observed between mammalian orthologs. Still, all of the residues thought to be important for alpha(2)-adrenergic ligand binding are conserved across species and subtypes, and even the most divergent regions of the fish receptors show clear "molecular fingerprints" typical for orthologs of a given subtype.


Subject(s)
Evolution, Molecular , Gene Duplication , Phylogeny , Receptors, Adrenergic, alpha-2/genetics , Zebrafish/genetics , Animals , Base Sequence , Blotting, Southern , Chromosome Mapping , Gene Library , Molecular Sequence Data , Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sequence Analysis, DNA , Sequence Homology
10.
Br J Pharmacol ; 140(2): 347-58, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12970108

ABSTRACT

1. The structural determinants of catechol hydroxyl interactions with adrenergic receptors were examined using 12 alpha2-adrenergic agonists and a panel of mutated human alpha2A-adrenoceptors. The alpha2ASer201 mutant had a Cys --> Ser201 (position 5.43) amino-acid substitution, and alpha2ASer201Cys200 and alpha2ASer201Cys204 had Ser --> Cys200 (5.42) and Ser --> Cys204 (5.46) substitutions, respectively, in addition to the Cys --> Ser201 substitution. 2. Automated docking methods were used to predict the receptor interactions of the ligands. Radioligand-binding assays and functional [35S]GTPgammaS-binding assays were performed using transfected Chinese hamster ovary cells to experimentally corroborate the predicted binding modes. 3. The hydroxyl groups of phenethylamines were found to have different effects on ligand affinity towards the activated and resting forms of the wild-type alpha2A-adrenoceptor. Substitution of Ser200 or Ser204 with cysteine caused a deterioration in the capability of catecholamines to activate the alpha2A-adrenoceptor. The findings indicate that (i) Cys201 plays a significant role in the binding of catecholamine ligands and UK14,304 (for the latter, by a hydrophobic interaction), but Cys201 is not essential for receptor activation; (ii) Ser200 interacts with the meta-hydroxyl group of phenethylamine ligands, affecting both catecholamine binding and receptor activation; while (iii) substituting Ser204 with a cysteine interferes both with the binding of catecholamine ligands and with receptor activation, due to an interaction between Ser204 and the para-hydroxyl group of the catecholic ring.


Subject(s)
Idazoxan/analogs & derivatives , Ligands , Membrane Proteins/metabolism , Receptors, Adrenergic, alpha-2/metabolism , Adrenergic Agonists/metabolism , Adrenergic Agonists/pharmacology , Amino Acid Sequence , Amino Acid Substitution , Animals , Binding Sites/genetics , Binding, Competitive/drug effects , Brimonidine Tartrate , CHO Cells , Catecholamines/chemistry , Catecholamines/metabolism , Cricetinae , Guanosine 5'-O-(3-Thiotriphosphate)/metabolism , Idazoxan/metabolism , Membrane Proteins/chemistry , Membrane Proteins/genetics , Models, Molecular , Molecular Structure , Mutation , Protein Structure, Tertiary , Quinoxalines/chemistry , Quinoxalines/metabolism , Radioligand Assay , Receptors, Adrenergic, alpha-2/chemistry , Receptors, Adrenergic, alpha-2/genetics , Sequence Homology, Amino Acid , Sulfur Radioisotopes , Tritium
SELECTION OF CITATIONS
SEARCH DETAIL
...